Sterne Kessler Wins $9.5 Million Jury Verdict for Mallinckrodt Pharmaceuticals in Patent Suit
MDRX(MDRX) WASHINGTON--(BUSINESS WIRE)--Sterne, Kessler, Goldstein & Fox won a $9.5 million jury verdict on behalf of Mallinckrodt Pharmaceuticals in a patent infringement lawsuit filed in the U.S. District Court for the District of Delaware over Mallinckrodt’s INOmax (nitric oxide for inhalation) drug product and associated nitric oxide delivery device. Mallinckrodt first brought suit under the Hatch-Waxman Act against Airgas Therapeutics in 2022, arguing that Airgas’s Abbreviated New Drug Applicatio
ModMed Replaces Time-Consuming Faxing Workflows with AI-Powered Enhanced Faxing for EMA
MDRXBOCA RATON, Fla.--(BUSINESS WIRE)--ModMed®, a leader in healthcare technology, today announced a major advancement aimed at relieving healthcare providers from heavy administrative burdens. With the release of Enhanced Faxing for EMA®, which uses AI to categorize, extract and direct key information from the faxed document directly into the EHR with minimal human intervention, ModMed is streamlining one of healthcare's most stubborn manual processes: faxing. Unlike third-party fax solutions that
Veradigm Amends and Extends Stockholder Rights Plan
MDRXCHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan for an additional six months (the “Rights Plan”). The Rights Plan, adopted on February 26, 2024, was due to expire at 5:00PM New York City time on August 20, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration
Veradigm Appoints Don Trigg as Chief Executive Officer
MDRXCHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that its Board of Directors has appointed Don Trigg, an industry leader with over two decades of healthcare technology experience, as the Company’s new Chief Executive Officer and member of the Board, effective as of September 2, 2025. Trigg was most recently CEO of apree health. The company, acquired by Elevance Health in 2024, develops and delivers innovative ad
Veradigm to Release Business Update June 23rd and Host Investor Call June 24th
MDRXCHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a business update after the close of regular stock market hours on June 23, 2025. Veradigm management plans to host an investor conference call and webcast the Company’s update at 8:00 a.m. Eastern Time on June 24, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of regular stock marke
A Preview Of Allscripts Healthcare's Earnings
MDRXAllscripts Healthcare (NASDAQ:MDRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement.
Analysts estimate that Allscripts Healthcare will report an earnings per share (EPS) of $0.21.